Great video interview of CEO David Elsley of Cardiol Therapeutics Inc. as he discusses @CardiolRx , the fight against #covid19, their upcoming studies and clinical trials, and their recent uplisting to @Nasdaq -
Symbol: $CRDL
@grassosteve@GantosJ
https://t.co/ed3MitnDjU
$CRDL $CRTPF - I subscribe to #investorsdigest 🇨🇦. Nice surprise seeing @CardiolRx mentioned in their latest digest issue discussing the need for therapies to help combat the #cardiovascular consequences of #COVID . A great read from a highly respected publication 👍@grassosteve
PRESS RELEASE: Cardiol Therapeutics Announces First Patient Enrolled in LANCER, a Phase II/III Outcomes Trial in High-risk Patients Hospitalized with COVID-19
Read the full press release: https://t.co/pMGvgi0HZ7
$CRDL $CRTPF
WATCH: David Elsley, President & CEO joined @stevedarling from @Proactive_ca to talk about @CardiolRx recent announcement of topline results from a Phase I clinical trial of CardiolRx™ $CRDL $CRTPF
https://t.co/ES19mUuxPZ
Listen to David Elsley, our President & CEO, in an interview with @nickchodge from @dailyprofcycle on Cardiol's new analyst report, clinical development pipeline, and upcoming catalysts for the company. $CRDL $CRTPF
Full transcript available.
https://t.co/XuaArFQ7fX
$AMGN $CRDL $CRTPF - Dr. Hamer left @Amgen to join Cardiol. Amgen trades today at $255.00 per share!! Good days ahead for Cardiol?? I say yes! Do your own DD.
Cardiol Appoints Dr. Andrew Hamer as New Chief Medical Officer - Cardiol Therapeutics https://t.co/LuGQxLO3zP
PRESS RELEASE: Cardiol Therapeutics Appoints Dr. Andrew Hamer as New Chief Medical Officer
Read the full press release: https://t.co/dAvk5CfA14
$CRDL $CRTPF
Found this today on proactive investors !! @CardiolRx $CRDL $CRTPF gets 'Speculative Buy' rating as Leede Jones Gable initiates coverage 👍. I like it!
@grassosteve
https://t.co/knQ7jSf55g
$CRDL $CRTPF ~ Very nice to see my @CardiolRx added to @THCX_ETF , buying over 1 million shares!! This 🇺🇸 ETF also holds @gwpharma , @tilray & @aphriainc . This will definitely bring additional exposure to Cardiol Therapeutics. 👍 @grassosteve
WATCH: David Elsley, President & CEO joined Steve Darling from Proactive Investors to discuss submitting an application to uplist to the Nasdaq Exchange $CRDL $CRTPF #NASDAQ
https://t.co/RKH97QmRwi
PRESS RELEASE: Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over
$10 Million from Exercise of Warrants and Options
Read the full press release: https://t.co/4K6939HQAw
$CRDL $CRTPF - Great news out this morning from @CardiolRx ! #NASDAQ bound. Co. raised $10,000,000 dollars from recent exercise of warrants. Cashed up as they initiate a Phase II/III clinical trial program in the #USA against #COVID19 👍
@grassosteve
https://t.co/kkkUvbIB0o
Here we go... this will give visibility to a whole new investor! Should be Tremendous tailwind for the stock $CRTPF $CRDL ..I am an advisor to @CardiolRx !